Forget about saving British big pharma – it’s little pharma we should be helping

Readers in all sorts of places — at the club bar, over a birthday lunch, even along the church pew — had been telling me I was wrong not to subscribe to the ‘save AstraZeneca’ campaign, and too complacent about the future of British science when I wrote: ‘the game is Pfizer’s for the taking, as soon as the price is right’.

Already a subscriber? Log in

Subscribe for just $2 a week

Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.

Unlimited access to spectator.com.au and app
The weekly edition on the Spectator Australia app
Spectator podcasts and newsletters
Full access to spectator.co.uk

Unlock this article

TaggedAstraZeneca, Emma Duncan, Pfizer, pharma, Recession, saving the high street, Sunday Times Rich List, superstores, town centres

Comments

Don't miss out

Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.

Already a subscriber? Log in

Forget about saving British big pharma – it's little pharma we should be helping

Plus: In praise of the high street, and why the Rich List should be a set text for sixth-formers

Subscribe for just $2 a week